Cobolimab with dostarlimab and docetaxel for treating advanced non-small-cell lung cancer after anti-PD-L1 treatment and chemotherapy [ID6398] Technology appraisal guidance TBC COLOFIT algorithm to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results